Results 121 to 130 of about 6,730 (183)

Efficacy and safety of hetrombopag, a novel thrombopoietin receptor agonist, in children and adolescents with immune thrombocytopenia: results from a randomized, multicenter, placebo-controlled phase 3 trial. [PDF]

open access: yesJ Hematol Oncol
Wu R   +19 more
europepmc   +1 more source

Real-World Use of Avatrombopag in Children and Adolescents With Immune Thrombocytopenia. [PDF]

open access: yesPediatr Blood Cancer
Harris EM   +6 more
europepmc   +1 more source

Case Report: A case of pediatric persistent refractory ITP responsive to avatrombopag. [PDF]

open access: yesFront Immunol
Sau A   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy